International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-1 doi: 10.5281/zenodo.7676194
Original Article
A Comparative Study between Desarda and Mesh Hernioplasty (Lichtenstein) in Inguinal Hernia: A multi-centre Experience
Abstract
Introduction: Inguinal hernia is a common problem and its repair is one of the most commonly performed procedures in general surgical practice. Several methods have been developed including Lichtenstein’s repair. Among these Lichtenstein’s repair has been the standard technique for the last few decades. In recent times a new procedure “no mesh Desarda hernia repair” has emerged as a recognized operative method for inguinal hernia repair. Aim of the study: The aim of the study was to find out the efficacy and safety profile between Desarda and Mesh Hernioplasty (Lichtenstein) in Inguinal Hermia. Methods: A comparative study between the 50 patients undergoing open mesh and Desarda repair was done based on randomization. All patients were diagnosed with an inguinal hernia from January 2019 to December 2020 at Khulna Medical College and Hospital, Khulna, Bangladesh and some private hospital, Khulna, Bangladesh. Result: During follow up, 5 (20.00%) patients suffered from chronic pain in lictenstein group compared to 3(12.00%) patients in desarda, Recurrence was 4(20.00%) seen in lictenstein group compared to 1 (4.00%) patients in desarda. Seroma was seen in 1 patients in desarda and nil in L group whereas hematoma was seen more in L group. Conclusion: The results of the study showed that the effectiveness of the Desarda technique with respect to influencing the early clinical outcomes of hernia repair is similar to that of the Lichtenstein method. However, the operator in this study showed that the Desarda repair requires significantly shorter operative time, is painless, and less Hospital stays with cost-effectiveness.
Recommended Articles
Loading Image...
Volume-4, Issue-1
Citations
2152 Views
499 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved